Dr Nicky Longley

Tel: 020 3447 9761
Email: n.longley@nhs.net

Location:
Hospital for Tropical Diseases

Specialities:
Tropical and infectious diseases

Professional background

Qualified from St Georges, University of London and then trained in Infectious diseases and medical microbiology in London. Has extensive clinical and academic experiences in infectious diseases and HIV medicine from her work in both Uganda and South Africa. After her Wellcome Trust Clinical Training Fellowship in epidemiology and Tropical Medicine based in Cape Town she took up the post as an infectious diseases consultant and the clinical lead for Travel Medicine at the Hospital of Tropical Diseases alongside her role as a clinical lecturer at The London School of Hygiene and Tropical Medicine.

Research interests

The immunosupressed traveller

Publications

  • Implementation and Operational Research: Evaluation of a Public-Sector, Provider-Initiated Cryptococcal Antigen Screening and Treatment Program, Western Cape, South Africa.
    Vallabhaneni S, Longley N, Smith M, Smith R, Osler M, Kelly N, Cross A, Boulle A, Meintjes G, Govender NP. J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e37-e42
  • Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study
    Longley N, Jarvis JN, Meintjes G, Boulle A, Cross A, Kelly N, Govender NP, Bekker LG, Wood R, Harrison TS. Clin Infect Dis. 2016 Mar 1;62(5):581-587
  • AIDS-related mycoses: the way forward
    Brown GD, Meintjes G, Kolls JK, Gray C, Horsnell W; Working Group from the EMBO-AIDS Related Mycoses Workshop, Trends Microbiol. 2014 Mar;22(3):107-9.
  • Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes
    Jarvis JN, Bicanic T, Loyse A, Namarika D, Jackson A, Nussbaum JC, Longley N, Muzoora C, Phulusa J, Taseera K, Kanyembe C, Wilson D, Hosseinipour MC, Brouwer AE, Limmathurotsakul D, White N, van der Horst C, Wood R, Meintjes G, Bradley J, Jaffar S, Harrison T. Clin Infect Dis. 2014 Mar;58(5):736-45
  • Cryptococcal immune reconstitution inflammatory syndrome.
    Longley N, Harrison TS, Jarvis JN. Curr Opin Infect Dis. 2013 Feb;26(1):26-34
  • Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation
    Jarvis JN, Govender N, Chiller T, Park B, Longley N, Meintjes G, Bekker LG, Wood R, Lawn SD, Harrison TS J Int Assoc Physicians AIDS Care (Chic). 2012 Nov-Dec;11(6):374-9
  • Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis.
    Muzoora CK, Kabanda T, Ortu G, Ssentamu J, Hearn P, Mwesigye J, Longley N, Jarvis JN, Jaffar S, Harrison TS. J Infect. 2012 Jan;64(1):76-81
  • Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis.
    Jarvis JN, Percival A, Bauman S, Pelfrey J, Meintjes G, Williams GN, Longley N, Harrison TS, Kozel TR. Clin Infect Dis. 2011 Nov;53(10):1019-23.
  • Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts: time to implement in South Africa?
    Jarvis JN, Harrison TS, Govender N, Lawn SD, Longley N, Bicanic T, Maartens G, Venter F, Bekker LG, Wood R, Meintjes G. S Afr Med J. 2011 Apr;101(4):232-4.
  • Severe Guillain-BarrĂ© syndrome following primary infection with varicella zoster virus in an adult.
    Cresswell F, Eadie J, Longley N, Macallan D. Int J Infect Dis. 2010 Feb;14(2):e161-3.
  • Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.
    Bicanic T, Muzoora C, Brouwer AE, Meintjes G, Longley N, Taseera K, Rebe K, Loyse A, Jarvis J, Bekker LG, Wood R, Limmathurotsakul D, Chierakul W, Stepniewska K, White NJ, Jaffar S, Harrison TS. Clin Infect Dis. 2009 Sep 1;49(5):702-9
  • Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.
    Longley N, Muzoora C, Taseera K, Mwesigye J, Rwebembera J, Chakera A, Wall E, Andia I, Jaffar S, Harrison TS. Clin Infect Dis. 2008 Dec 15;47(12):1556-61

GMC/GDC number: 4733614